<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
CARDIAC SCIENCE, INC.
(Name of Issuer)
COMMON STOCK, PAR VALUE $0.001 PER SHARE
(Title of Class of Securities)
141410-209
(CUSIP Number)
WALTER VILLIGER
HURDNERSTRASSE 10
POSTFACH 1474
CH-8640, HURDEN
SWITZERLAND
(41) 55-415-1111
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
COPIES TO:
SHIVBIR S. GREWAL, ESQ.
STRADLING YOCCA CARLSON & RAUTH
660 NEWPORT CENTER DRIVE, SUITE, 1600
NEWPORT BEACH, CA 92660
TELEPHONE: (949) 725-4000
FEBRUARY 3, 2000
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed on Schedule 13G to report the
acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following
box. / /
<PAGE>
<TABLE>
SCHEDULE 13D
- ---------------------------------------- -------------------------------------
CUSIP NO. 141410-209 PAGE 2 OF 16 PAGES
- ---------------------------------------- -------------------------------------
=========== =========================================================================================================
<S> <C>
1 NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Walter Villiger
- ----------- ---------------------------------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) / /
(b) /X/
- ----------- ---------------------------------------------------------------------------------------------------------
3 SEC USE ONLY
- ----------- ---------------------------------------------------------------------------------------------------------
4 SOURCE OF FUNDS
PF
- ----------- ---------------------------------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEM 2(d) or 2(e)
/ /
- ----------- ---------------------------------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Switzerland
- ----------- ---------------------------------------------------------------------------------------------------------
NUMBER OF SHARES
BENEFICIALLY OWNED 7 SOLE VOTING POWER
BY EACH REPORTING
PERSON WITH 933,750
-------- ----------------------------------------------------------------------
8 SHARED VOTING POWER
0
-------- ----------------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
933,750
-------- ----------------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
0
- ----------- ---------------------------------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
933,750
- ----------- ---------------------------------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES
/ /
- ----------- ---------------------------------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
7.6%
- ----------- ---------------------------------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IN
=========== =========================================================================================================
</TABLE>
<PAGE>
SCHEDULE 13D
ITEM 1. SECURITY AND ISSUER.
SECURITY: COMMON SHARES
ISSUER: CARDIAC SCIENCE, INC.
16931 MILLIKAN AVENUE
IRVINE, CALIFORNIA 92606
RAYMOND W. COHEN - PRESIDENT AND CHIEF EXECUTIVE
OFFICER
BRETT L. SCOTT - CHIEF FINANCIAL OFFICER AND
SECRETARY
ITEM 2. IDENTITY AND BACKGROUND.
(a) WALTER VILLIGER (REPORTING PERSON)
(b) HURDNERSTRASSE 10
POSTFACH 1474
CH-8640, HURDEN
SWITZERLAND
(c) PASSIVE INVESTMENTS.
(d) NONE.
(e) NONE.
(f) SWITZERLAND
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.
PERSONAL FUNDS.
ITEM 4. PURPOSE OF TRANSACTION.
PASSIVE INVESTMENT. ALTHOUGH THERE IS NO CURRENT INTENTION TO DO SO,
THE REPORTING PERSON MAY IN THE FUTURE ACQUIRE OR DISPOSE OF SECURITIES
OF THE ISSUER.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
(a) - 900,000 SHARES OF COMMON STOCK;
- 33,750 WARRANTS, EACH CONVERTIBLE INTO ONE SHARE OF COMMON
STOCK, AT AN EXERCISE PRICE OF $5.00
- TOTAL BENEFICIAL OWNERSHIP (ASSUMING EXERCISE OF WARRANTS)
- 7.6%
(b) REPORTING PERSON HAS THE SOLE POWER TO VOTE, OR TO DIRECT THE
VOTE OF, ALL OF THE SHARES SET FORTH IN PARAGRAPH (a).
(c) THE REPORTING PERSON HAS NOT
<PAGE>
EFFECTED ANY TRANSACTION IN THE COMMON STOCK IN THE PAST 60
DAYS. 50,000 SHARES WERE PURCHASED OVERSEAS BY THE REPORTING
PERSON IN A PRIVATE THIRD PARTY TRANSACTION, ON FEBRUARY 3,
2000, AT A PRICE OF $3.00 PER SHARE.
(d) THE REPORTING PERSON HAS REGISTERED 850,000 SHARES OF COMMON
STOCK AND 37,750 WARRANTS IN THE STREET NAME OF LAMONT ASSET
MANAGEMENT, ZURICH, SWITZERLAND, ALTHOUGH THE VOTING CONTROL
AND POWER OF DISPOSITION THEREOF REMAINS IN THE CONTROL OF THE
REPORTING PERSON.
(e) NOT APPLICABLE.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH
RESPECT TO SECURITIES OF THE ISSUER.
SEE RESPONSE TO ITEM 5(d). NONE OF THE SECURITIES ARE PLEDGED
OR SUBJECT TO A CONTINGENCY THE OCCURRENCE OF WHICH WOULD GIVE
ANOTHER PERSON VOTING OR INVESTMENT POWER OVER SUCH
SECURITIES.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS.
NONE
<PAGE>
SIGNATURE
AFTER REASONABLE INQUIRY AND TO THE BEST OF MY KNOWLEDGE AND BELIEF, I
CERTIFY THAT THE INFORMATION SET FORTH IN THIS STATEMENT IS TRUE,
COMPLETE AND CORRECT.
DATE: APRIL 29, 2000 /s/WALTER VILLIGER
-------------------------------------------
WALTER VILLIGER
